{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:02:35Z","timestamp":1761843755978},"reference-count":71,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiology Clinics"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1016\/j.ccl.2007.12.012","type":"journal-article","created":{"date-parts":[[2008,4,12]],"date-time":"2008-04-12T17:19:08Z","timestamp":1208020748000},"page":"299-309","source":"Crossref","is-referenced-by-count":19,"title":["Perioperative Management of Oral Anticoagulation"],"prefix":"10.1016","volume":"26","author":[{"given":"Martin","family":"O'Donnell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clive","family":"Kearon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"21","key":"10.1016\/j.ccl.2007.12.012_bib1","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1056\/NEJM199705223362107","article-title":"Management of anticoagulation before and after elective surgery","volume":"336","author":"Kearon","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ccl.2007.12.012_bib2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1023\/A:1012746729537","article-title":"Perioperative management of the chronically anticoagulated patient","volume":"12","author":"Heit","year":"2002","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.ccl.2007.12.012_bib3","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1001\/archinte.163.8.881","article-title":"The perioperative management of warfarin therapy","volume":"163","author":"Ansell","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ccl.2007.12.012_bib4","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1001\/archinte.163.8.901","article-title":"Perioperative management of patients receiving oral anticoagulants: a systematic review","volume":"163","author":"Dunn","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ccl.2007.12.012_bib5","doi-asserted-by":"crossref","first-page":"22S","DOI":"10.1378\/chest.119.1_suppl.22S","article-title":"Managing oral anticoagulant therapy","volume":"119","author":"Ansell","year":"2001","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.ccl.2007.12.012_bib6","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1076-7460.2005.02282.x","article-title":"Anticoagulation for atrial fibrillation in the elderly","volume":"14","author":"Halperin","year":"2005","journal-title":"Am J Geriatr Cardiol"},{"key":"10.1016\/j.ccl.2007.12.012_bib7","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1001\/jama.279.6.458","article-title":"Risk of fatal pulmonary embolism in patients with treated venous thromboembolism","volume":"279","author":"Douketis","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.ccl.2007.12.012_bib8","doi-asserted-by":"crossref","first-page":"338S","DOI":"10.1378\/chest.126.3_suppl.338S","article-title":"Prevention of\u00a0venous thromboembolism","volume":"126","author":"Geerts","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.ccl.2007.12.012_bib9","doi-asserted-by":"crossref","first-page":"40","DOI":"10.7326\/0003-4819-122-1-199501010-00006","article-title":"Temporary discontinuation of warfarin therapy: changes in the international normalized ratio","volume":"122","author":"White","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ccl.2007.12.012_bib10","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1345\/aph.10305","article-title":"Dalteparin as periprocedure anticoagulation for patients on warfarin and at high risk of thrombosis","volume":"35","author":"Tinmouth","year":"2001","journal-title":"Ann Pharmacother"},{"issue":"12","key":"10.1016\/j.ccl.2007.12.012_bib11","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1161\/01.CIR.0000142859.77578.C9","article-title":"Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin","volume":"110","author":"Kovacs","year":"2004","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.ccl.2007.12.012_bib12","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/archinte.164.12.1319","article-title":"Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen","volume":"164","author":"Douketis","year":"2004","journal-title":"Arch Intern Med"},{"issue":"11","key":"10.1016\/j.ccl.2007.12.012_bib13","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1111\/j.1538-7836.2007.02729.x","article-title":"Bridging therapy in patients with long-term oral anticoagulants who require surgery: the Prospective Peri-operative Enoxaparin Cohort trial (PROSPECT)","volume":"5","author":"Dunn","year":"2007","journal-title":"J\u00a0Thromb Haemost"},{"issue":"16","key":"10.1016\/j.ccl.2007.12.012_bib14","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1001\/archinte.158.16.1809","article-title":"Expanding eligibility for outpatient treatment of deep venous thrombosis and pulmonary embolism with low-molecular-weight heparin: a comparison of patient self-injection with homecare injection","volume":"158","author":"Wells","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ccl.2007.12.012_bib15","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0002-9149(99)00341-0","article-title":"Use of enoxaparin for the chronically anticoagulated patient before and after procedures","volume":"84","author":"Spandorfer","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ccl.2007.12.012_bib16","first-page":"II-826","article-title":"Temporary discontinuation of oral anticoagulants: role of low molecular weight heparin (Dalteparin)","volume":"102","author":"Turpie","year":"2002","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ccl.2007.12.012_bib17","doi-asserted-by":"crossref","first-page":"184","DOI":"10.7326\/0003-4819-146-3-200702060-00007","article-title":"Prevalence of residual anticoagulant activity following bridging low molecular weight heparin","volume":"146","author":"O'Donnell","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ccl.2007.12.012_bib18","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1067\/mhj.2002.120774","article-title":"Influence of patient characteristics and renal function on factor Xa inhibition pharmacokinetics and pharmacodynamics after enoxaparin administration in non-ST-segment elevation acute coronary syndromes","volume":"143","author":"Becker","year":"2002","journal-title":"Am Heart J"},{"issue":"1","key":"10.1016\/j.ccl.2007.12.012_bib19","first-page":"37","article-title":"Thromboprophylaxis with twice-daily but not with once-daily low-molecular-weight heparin is associated with a detectable anticoagulant effect at time of epidural catheter removal in patients receiving co-administered continuous epidural analgesia","volume":"88","author":"Douketis","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ccl.2007.12.012_bib20","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1001\/archinte.158.15.1610","article-title":"Dental surgery in anticoagulated patients","volume":"158","author":"Wahl","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ccl.2007.12.012_bib21","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1056\/NEJM198903303201305","article-title":"Hemostatic effect of tranexamic acid mouthwash in anticoagulant-treated patients undergoing oral surgery","volume":"320","author":"Sindet-Pederson","year":"1989","journal-title":"N Engl J Med"},{"issue":"Pt 6","key":"10.1016\/j.ccl.2007.12.012_bib22","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/eye.1993.174","article-title":"Management of the anticoagulated patient for ophthalmic surgery","volume":"7","author":"McCormack","year":"1993","journal-title":"Eye"},{"key":"10.1016\/j.ccl.2007.12.012_bib23","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0016-5107(98)70057-4","article-title":"Guideline on the management of anticoagulation and antiplatelet therapy for endoscopic procedures. American Society for Gastrointestinal Endoscopy","volume":"48","year":"1998","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.ccl.2007.12.012_bib24","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1001\/jama.1978.03280350062016","article-title":"Discontinuing anticoagulant therapy in surgical patients with cardiac valve prostheses: observations in 180 operations","volume":"239","author":"Tinker","year":"1978","journal-title":"JAMA"},{"key":"10.1016\/j.ccl.2007.12.012_bib25","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1001\/jama.1983.03330270038029","article-title":"Two-step warfarin therapy: prevention of postoperative venous thrombosis without excessive bleeding","volume":"249","author":"Francis","year":"1983","journal-title":"JAMA"},{"key":"10.1016\/j.ccl.2007.12.012_bib26","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1136\/bmj.1.6108.272","article-title":"Oral anticoagulants controlled by the British comparative thromboplastin versus low-dose heparin in prophylaxis of deep vein thrombosis","volume":"1","author":"Taberner","year":"1978","journal-title":"Br Med J"},{"key":"10.1016\/j.ccl.2007.12.012_bib27","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.0954-6820.1963.tb16512.x","article-title":"Surgery during anticoagulant treatment: the risk of increased bleeding in patients on oral anticoagulant treatment","volume":"173","author":"Rustad","year":"1963","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.ccl.2007.12.012_bib28","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1055\/s-0038-1650352","article-title":"Comparison of two warfarin regimens in the prevention of venous thrombosis following total knee replacement","volume":"75","author":"Francis","year":"1996","journal-title":"Thromb Haemost"},{"issue":"6","key":"10.1016\/j.ccl.2007.12.012_bib29","doi-asserted-by":"crossref","first-page":"393","DOI":"10.7326\/0003-4819-135-6-200109180-00008","article-title":"Clinical predictors of prolonged delay in return of the international normalized ratio to within the therapeutic range after excessive anticoagulation with warfarin","volume":"135","author":"Hylek","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ccl.2007.12.012_bib30","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/S0140-6736(00)03125-1","article-title":"Treatment of warfarin-associated coagulopathy with oral vitamin K: a randomised controlled trial","volume":"356","author":"Crowther","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ccl.2007.12.012_bib31","doi-asserted-by":"crossref","first-page":"260","DOI":"10.4065\/76.3.260","article-title":"Efficacy and safety of intravenous phytonadione (vitamin K1) in patients on long-term oral anticoagulant therapy","volume":"76","author":"Shields","year":"2001","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ccl.2007.12.012_bib32","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1161\/01.CIR.98.18.1949","volume":"98","author":"Bonow","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.ccl.2007.12.012_bib33","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1001\/archinte.1994.00420130036007","article-title":"Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation analysis of pooled data from five randomized trials","volume":"154","author":"Atrial Fibrillation Investigators","year":"1994","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ccl.2007.12.012_bib34","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1001\/archinte.158.12.1316","article-title":"Echocardiographic predictors of stroke in patients with atrial fibrillation","volume":"158","author":"Atrial Fibrillation Investigators","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ccl.2007.12.012_bib35","doi-asserted-by":"crossref","first-page":"688","DOI":"10.7326\/0003-4819-131-9-199911020-00010","article-title":"Atrial fibrillation and thromboembolism: a decade of progress in stroke prevention","volume":"131","author":"Hart","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ccl.2007.12.012_bib36","doi-asserted-by":"crossref","first-page":"429S","DOI":"10.1378\/chest.126.3_suppl.429S","article-title":"Antithrombotic therapy in atrial fibrillation","volume":"126","author":"Singer","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.ccl.2007.12.012_bib37","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1161\/01.CIR.72.5.1059","article-title":"Warfarin versus dipyridamole-aspirin and pentoxifylline-aspirin for the prevention of prosthetic heart valve thromboembolism: a prospective randomized clinical trial","volume":"72","author":"Mok","year":"1985","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ccl.2007.12.012_bib38","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/01.CIR.89.2.635","article-title":"Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses","volume":"89","author":"Cannegieter","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.ccl.2007.12.012_bib39","first-page":"114","article-title":"Intracardiac thrombosis: patient-related and device-related factors","volume":"4","author":"Horstkotte","year":"1995","journal-title":"J Heart Valve Dis"},{"key":"10.1016\/j.ccl.2007.12.012_bib40","doi-asserted-by":"crossref","first-page":"457S","DOI":"10.1378\/chest.126.3_suppl.457S","article-title":"Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves","volume":"126","author":"Salem","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.ccl.2007.12.012_bib41","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/0140-6736(93)92358-Z","article-title":"Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke","volume":"342","author":"European Atrial Fibrillation Trial Study Group","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.ccl.2007.12.012_bib42","doi-asserted-by":"crossref","first-page":"401S","DOI":"10.1378\/chest.126.3_suppl.401S","article-title":"Antithrombotic therapy for venous thromboembolic disease","volume":"126","author":"Buller","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.ccl.2007.12.012_bib43","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/S0140-6736(00)02085-7","article-title":"Low molecular-weight heparin versus aspirin in patients with acute ischaemic stroke and atrial fibrillation: a double-blind randomised study. HAEST Study Group. Heparin in Acute Embolic Stroke Trial","volume":"355","author":"Berge","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ccl.2007.12.012_bib44","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1161\/01.STR.0000035735.49388.4A","article-title":"Atrial fibrillation, stroke, and acute antithrombotic therapy: analysis of randomized clinical trials","volume":"33","author":"Hart","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.ccl.2007.12.012_bib45","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0140-6736(01)05837-8","article-title":"Tinzaparin in acute ischaemic stroke (TAIST): a randomised aspirin-controlled trial","volume":"358","author":"Bath","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ccl.2007.12.012_bib46","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1161\/01.STR.31.7.1770","article-title":"Low-molecular-weight heparins and heparinoids in acute ischemic stroke: a meta-analysis of randomized controlled trials","volume":"31","author":"Bath","year":"2000","journal-title":"Stroke"},{"issue":"10","key":"10.1016\/j.ccl.2007.12.012_bib47","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1161\/hs1001.097093","article-title":"Risk of early death and recurrent stroke and effect of heparin in 3169 patients with accute ischemic stroke and atrial fibrillation in the International Stroke Trial","volume":"32","author":"Saxena","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.ccl.2007.12.012_bib48","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1056\/NEJM199703203361207","article-title":"Aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial infarction","volume":"336","author":"Collins","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ccl.2007.12.012_bib49","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/archinte.160.2.191","article-title":"Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature","volume":"160","author":"Chan","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ccl.2007.12.012_bib50","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1016\/0735-1097(96)00072-1","article-title":"Failure of adjusted doses of subcutaneous heparin to prevent thromboembolic phenomena in pregnant patients with mechanical cardiac valve prostheses","volume":"27","author":"Salazar","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ccl.2007.12.012_bib51","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1161\/01.CIR.101.10.1083","article-title":"Low molecular weight heparin after mechanical heart valve replacement","volume":"101","author":"Montalescot","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ccl.2007.12.012_bib52","first-page":"326","article-title":"Perioperative anticoagulation in patients with chronic atrial fibrillation who are undergoing elective surgery: results of a physician survey","volume":"16","author":"Douketis","year":"2000","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.ccl.2007.12.012_bib53","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1378\/chest.116.5.1240","article-title":"Physician preferences for perioperative anticoagulation in patients with a mechanical heart valve who are undergoing elective noncardiac surgery","volume":"116","author":"Douketis","year":"1999","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.ccl.2007.12.012_bib54","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s11239-005-0346-5","article-title":"Perioperative anticoagulation for patients with mechanical heart valves: a survey of current practice","volume":"18","author":"Garcia","year":"2004","journal-title":"J Thromb Thrombolysis"},{"issue":"1","key":"10.1016\/j.ccl.2007.12.012_bib55","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1001\/archinternmed.2007.23","article-title":"Risk of thromboembolism with short-term interruption of warfarin therapy","volume":"168","author":"Garcia","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ccl.2007.12.012_bib56","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1001\/archinte.163.6.694","article-title":"Anticoagulation of pregnant women with mechanical heart valves","volume":"163","author":"Ginsberg","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ccl.2007.12.012_bib57","first-page":"823","article-title":"Recurrence of venous thromboembolism","volume":"73","author":"Coon","year":"1973","journal-title":"Surgery"},{"key":"10.1016\/j.ccl.2007.12.012_bib58","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1001\/archinte.160.6.761","article-title":"Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study","volume":"160","author":"Heit","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ccl.2007.12.012_bib59","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1056\/NEJM199311043291902","article-title":"A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation","volume":"329","author":"Hull","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ccl.2007.12.012_bib60","doi-asserted-by":"crossref","first-page":"932","DOI":"10.2106\/00004623-199907000-00005","article-title":"Comparison of enoxaparin and warfarin for the prevention of venous thromboembolic disease after total hip arthroplasty","volume":"81-A","author":"Colwell","year":"1999","journal-title":"J Bone Joint Surg"},{"key":"10.1016\/j.ccl.2007.12.012_bib61","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1056\/NEJM199005033221802","article-title":"Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis","volume":"322","author":"Hull","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ccl.2007.12.012_bib62","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1056\/NEJM198805053181805","article-title":"Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin","volume":"318","author":"Collins","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ccl.2007.12.012_bib63","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0140-6736(93)92614-Y","article-title":"Low molecular weight versus standard heparin for prevention of venous thromboembolism after major abdominal surgery","volume":"341","author":"Kakkar","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.ccl.2007.12.012_bib64","doi-asserted-by":"crossref","first-page":"874","DOI":"10.7326\/0003-4819-119-9-199311010-00002","article-title":"The weight-based heparin dosing nomogram compared with a standard care nomogram","volume":"119","author":"Raschke","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ccl.2007.12.012_bib65","doi-asserted-by":"crossref","first-page":"64S","DOI":"10.1378\/chest.119.1_suppl.64S","article-title":"Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety","volume":"119","author":"Hirsh","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.ccl.2007.12.012_bib66","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1056\/NEJM199802123380701","article-title":"A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis","volume":"338","author":"Decousus","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ccl.2007.12.012_bib67","doi-asserted-by":"crossref","first-page":"133","DOI":"10.7326\/0003-4819-126-2-199701150-00006","article-title":"Comparison of 5-mg and 10-mg loading doses in initiation of warfarin therapy","volume":"126","author":"Harrison","year":"1997","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.ccl.2007.12.012_bib68","doi-asserted-by":"crossref","first-page":"423","DOI":"10.7326\/0003-4819-76-3-112-6-423","article-title":"Very low doses of warfarin can prevent thrombosis in central venous catheters","volume":"112","author":"Bern","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ccl.2007.12.012_bib69","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMoa035029","article-title":"Long-term, low-intensity warfarin therapy for prevention of recurrent venous thromboembolism","volume":"348","author":"Ridker","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ccl.2007.12.012_bib70","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0140-6736(96)03487-3","article-title":"Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: stroke prevention in atrial fibrillation III randomised clinical trial","volume":"348","author":"Blackshear","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.ccl.2007.12.012_bib71","doi-asserted-by":"crossref","first-page":"300","DOI":"10.2165\/00003088-199630040-00003","article-title":"Warfarin withdrawal: pharmacokinetic-pharmacodynamic considerations","volume":"30","author":"Palareti","year":"1996","journal-title":"Clin Pharmacokinet"}],"container-title":["Cardiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733865107001506?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733865107001506?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T08:05:09Z","timestamp":1557475509000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733865107001506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":71,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S0733865107001506"],"URL":"https:\/\/doi.org\/10.1016\/j.ccl.2007.12.012","relation":{},"ISSN":["0733-8651"],"issn-type":[{"value":"0733-8651","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}